全文获取类型
收费全文 | 15216篇 |
免费 | 1231篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 142篇 |
儿科学 | 705篇 |
妇产科学 | 482篇 |
基础医学 | 2289篇 |
口腔科学 | 373篇 |
临床医学 | 1813篇 |
内科学 | 2986篇 |
皮肤病学 | 154篇 |
神经病学 | 1533篇 |
特种医学 | 626篇 |
外科学 | 1487篇 |
综合类 | 181篇 |
一般理论 | 8篇 |
预防医学 | 1553篇 |
眼科学 | 207篇 |
药学 | 945篇 |
中国医学 | 16篇 |
肿瘤学 | 966篇 |
出版年
2022年 | 66篇 |
2021年 | 186篇 |
2020年 | 154篇 |
2019年 | 246篇 |
2018年 | 260篇 |
2017年 | 247篇 |
2016年 | 273篇 |
2015年 | 273篇 |
2014年 | 380篇 |
2013年 | 598篇 |
2012年 | 803篇 |
2011年 | 943篇 |
2010年 | 447篇 |
2009年 | 431篇 |
2008年 | 773篇 |
2007年 | 782篇 |
2006年 | 780篇 |
2005年 | 771篇 |
2004年 | 736篇 |
2003年 | 656篇 |
2002年 | 687篇 |
2001年 | 448篇 |
2000年 | 421篇 |
1999年 | 400篇 |
1998年 | 196篇 |
1997年 | 164篇 |
1996年 | 137篇 |
1995年 | 176篇 |
1994年 | 175篇 |
1993年 | 145篇 |
1992年 | 298篇 |
1991年 | 303篇 |
1990年 | 244篇 |
1989年 | 252篇 |
1988年 | 239篇 |
1987年 | 187篇 |
1986年 | 181篇 |
1985年 | 177篇 |
1984年 | 157篇 |
1983年 | 131篇 |
1982年 | 95篇 |
1981年 | 120篇 |
1980年 | 76篇 |
1979年 | 107篇 |
1978年 | 82篇 |
1977年 | 92篇 |
1976年 | 74篇 |
1975年 | 85篇 |
1974年 | 100篇 |
1971年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
2.
3.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
4.
5.
Samir Gupta MD MSCS Gloria D. Coronado PhD Keith Argenbright MD Alison T. Brenner PhD MPH Sheila F. Castañeda PhD Jason A. Dominitz MD MHS Beverly Green MD MPH Rachel B. Issaka MD MAS Theodore R. Levin MD Daniel S. Reuland MD MPH Lisa C. Richardson MD MPH Douglas J. Robertson MD MPH Amit G. Singal MD MS Michael Pignone MD MPH 《CA: a cancer journal for clinicians》2020,70(4):283-298
Uptake of colorectal cancer screening remains suboptimal. Mailed fecal immunochemical testing (FIT) offers promise for increasing screening rates, but optimal strategies for implementation have not been well synthesized. In June 2019, the Centers for Disease Control and Prevention convened a meeting of subject matter experts and stakeholders to answer key questions regarding mailed FIT implementation in the United States. Points of agreement included: 1) primers, such as texts, telephone calls, and printed mailings before mailed FIT, appear to contribute to effectiveness; 2) invitation letters should be brief and easy to read, and the signatory should be tailored based on setting; 3) instructions for FIT completion should be simple and address challenges that may lead to failed laboratory processing, such as notation of collection date; 4) reminders delivered to initial noncompleters should be used to increase the FIT return rate; 5) data infrastructure should identify eligible patients and track each step in the outreach process, from primer delivery through abnormal FIT follow-up; 6) protocols and procedures such as navigation should be in place to promote colonoscopy after abnormal FIT; 7) a high-quality, 1-sample FIT should be used; 8) sustainability requires a program champion and organizational support for the work, including sufficient funding and external policies (such as quality reporting requirements) to drive commitment to program investment; and 9) the cost effectiveness of mailed FIT has been established. Participants concluded that mailed FIT is an effective and efficient strategy with great potential for increasing colorectal cancer screening in diverse health care settings if more widely implemented. 相似文献
6.
A workshop report on the development of the Cow's Milk‐related Symptom Score awareness tool for young children 下载免费PDF全文
7.
8.
9.